Aug 6, 2026 09:58AM
Aug 6, 2026 07:16AM
Aug 6, 2026 07:00AM
Aug 6, 2026 07:00AM
Aug 6, 2026 07:00AM
Jul 23, 2026 04:05PM
Jul 23, 2026 04:05PM Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
May 21, 2026 09:00AM
May 20, 2026 07:08AM
May 20, 2026 07:00AM
May 11, 2026 04:05PM
May 11, 2026 04:05PM
Feb 6, 2026 07:48AM
Feb 6, 2026 07:00AM Roivant reports positive Phase 2 results for brepocitinib in sarcoidosis
Feb 6, 2026 07:00AM
Jan 23, 2026 05:25PM
Jan 23, 2026 04:15PM
Nov 14, 2025 04:59AM
Nov 10, 2025 08:04AM
Nov 10, 2025 07:00AM
Oct 27, 2025 04:10PM Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
Oct 27, 2025 04:10PM
Aug 11, 2025 07:08AM
Aug 11, 2025 07:00AM
Jul 28, 2025 04:05PM
May 29, 2025 07:00AM
May 15, 2025 04:10PM
Feb 10, 2025 07:24AM Roivant Sciences Ltd. (ROIV) Tops Q3 EPS by 48c
Feb 10, 2025 07:00AM
Jan 29, 2025 04:05PM
Nov 12, 2024 04:26PM
Nov 12, 2024 07:00AM
Oct 29, 2024 04:35PM
Oct 28, 2024 09:25AM
Oct 28, 2024 09:25AM Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
Aug 8, 2024 07:45AM
Aug 8, 2024 07:00AM
Jul 25, 2024 04:05PM
May 30, 2024 07:29AM
May 30, 2024 07:00AM
May 16, 2024 04:05PM
Feb 13, 2024 07:08AM Roivant Sciences Ltd. (ROIV) Tops Q3 EPS by 634c
Feb 13, 2024 07:00AM
Jan 30, 2024 04:05PM
Nov 13, 2023 07:06AM
Nov 13, 2023 07:00AM
Oct 30, 2023 05:30PM
Oct 23, 2023 07:42AM
Aug 14, 2023 07:30AM Roivant Sciences (ROIV) reports higher-than-expected FQ1 loss
Aug 14, 2023 07:25AM

1,217,835 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All